Bioventix PLC

Bioventix PLC
Stock Exchange London Stock Exchange
EPS
GBP1.07
Market Cap
GBP202.88 M
Shares Outstanding
5.14 M
Public Float
4.29 M

Profile

Address
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
Employees -
Website http://bioventix.com
Updated 07/08/2019
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.

Financials

View All

Ian James Nicholson
Non-Executive Chairman
Peter J. Harrison
Chief Executive Officer & Director